中国医药产品对外贸易空间结构演化与 影响因素.

The development of pharmaceutical products and foreign trade cooperation are facing more and more serious challenges under the intertwined influence of emergencies such as the reshaping of the international value chain and COVID-19 infection. Based on the foreign trade data of Chinese pharmaceutical products, using the trade complementarity index and panel regression model, this paper studied the space evolution and influencing factors of the trade structure of Chinese pharmaceutical products from 2001 to 2021. The results show that the scale of foreign trade "starts low and grows fast", the trade deficit continues to increase, antibiotics have the most comparative advantages, and hormones have the most comparative disadvantages; In terms of spatial pattern, Chinese imports and exports are highly dependent on developed countries and regions in Europe and north America. Developing countries or regions also play a part in Chinese export. In terms of the impact mechanism, the gross domestic product, innovation input and output, aging and multi-dimensional proximity of trading countries are positively correlated with Chinese pharmaceutical product trade, and the degree of regional stability is negatively correlated with it. The impact of foreign direct investment is not significant. At the end of the article, the author provides relevant suggestions for the development of Chinese pharmaceutical industry from the perspective of trade market. [ABSTRACT FROM AUTHOR]